A newly identified protein that sparks the earliest stages of diabetic retinopathy could transform how the sight-threatening condition is treated,...
Read moreDetailsMacular Disease Foundation Australia (MDFA) is partnering with Diabetes Australia’s KeepSight to expand its Eye Connect service to include Australians...
Read moreDetailsZEISS has introduceed single-use lenses for the RESIGHT fundus viewing system, enhancing intraoperative retina visualisation in posterior segment surgeries. The...
Read moreDetailsPeople living with diabetes make an estimated 180 more health-related decisions each day than those without the condition – yet...
Read moreDetailsAutonomous AI technology for detection of eye disease is to be used in Norway, in what is thought to be...
Read moreDetailsA new Australian study has found that an automated AI camera can accurately detect diabetic eye disease with more than...
Read moreDetailsThe ninth edition of Ophthalmology Updates! has been a record-setting affair, with 250 delegates attending the 2025 conference to brush...
Read moreDetailsUltra-widefield optomap retinal imaging has transformed care at Rachel Cauchi Optometrists, where every patient is now screened on the device....
Read moreDetailsOphthalmology Updates! is returning for a ninth time with its most ambitious program yet, including a new cross-specialty session on...
Read moreDetailsPerfuse Therapeutics, Inc., a US biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, has announced positive results from...
Read moreDetails
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited